http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31828899

Outgoing Links

Predicate Object
contentType Journal Article
issn 1471-2466
issueIdentifier 1
pageRange 172-
publicationName BMC Pulmonary Medicine
startingPage 172
bibliographicCitation Yang Y, Liu Q, Cao L, Sun W, Gu X, Liu B, Xiao N, Teng F, Li X, Chen M, Yu W, Lin H, Xu G. Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment. BMC Pulmonary Medicine. 2021 May 19;21(1):172. doi: 10.1186/s12890-021-01539-x.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f48f5e80dcd71c1a3bc0e7b95a86eca1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8701da856e81bef255b7d39ab9f9092
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_471d11ecce5bfc6d64dfa1896ed762b8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0fa78026b41896e952e4079f3eaede4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_095e1e1d9200ba62b8d14434b9059104
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01f71ec062bc3366b5c5b958005f1777
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8a2572029d9d5f39390b6c80bd3ae9f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b2afa73b5301c35c1af9b337a5691ba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2cc586383cb8f7bee12cad19e2e9fc6c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8ca16502a1a844c80384fd3ff9aff15
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d730d02ae7453f585ca4083f6641cb70
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b56b1603ab8aa36096b3f3a495cf712
date 2021-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1186/s12890-021-01539-x
https://pubmed.ncbi.nlm.nih.gov/34011336
https://pubmed.ncbi.nlm.nih.gov/PMC8135149
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22335
https://portal.issn.org/resource/ISSN/1471-2466
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment
discusses http://id.nlm.nih.gov/mesh/M0593322
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M000603988
http://id.nlm.nih.gov/mesh/M0000268
http://id.nlm.nih.gov/mesh/M0001215
http://id.nlm.nih.gov/mesh/M0561143
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71496458
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10184653
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d

Total number of triples: 45.